164 related articles for article (PubMed ID: 38079423)
1. A non-socially-sensitive predictive model of prostate cancer for Asian males with benign prostatic hyperplasia: A multi-site cross-sectional case-control study.
Chang HJ; Moi SH; Chan YJ; Lan TY
PLoS One; 2023; 18(12):e0295608. PubMed ID: 38079423
[TBL] [Abstract][Full Text] [Related]
2. BPH: a tell-tale sign of prostate cancer? Results from the Prostate Cancer and Environment Study (PROtEuS).
Boehm K; Valdivieso R; Meskawi M; Larcher A; Sun M; Sosa J; Blanc-Lapierre A; Weiss D; Graefen M; Saad F; Parent MÉ; Karakiewicz PI
World J Urol; 2015 Dec; 33(12):2063-9. PubMed ID: 25824539
[TBL] [Abstract][Full Text] [Related]
3. Serum antibodies against genitourinary infectious agents in prostate cancer and benign prostate hyperplasia patients: a case-control study.
Hrbacek J; Urban M; Hamsikova E; Tachezy R; Eis V; Brabec M; Heracek J
BMC Cancer; 2011 Feb; 11():53. PubMed ID: 21291519
[TBL] [Abstract][Full Text] [Related]
4. A matched case-control study in Taiwan to evaluate potential risk factors for prostate cancer.
Chang HJ; Pong YH; Chiang CY; Huang PC; Wang MH; Chan YJ; Lan TY
Sci Rep; 2023 Mar; 13(1):4382. PubMed ID: 36928374
[TBL] [Abstract][Full Text] [Related]
5. [Herpes viruses and human papillomavirus in prostate cancer: first results].
Mikhaleva L M; Kamalov A A; Karpov V K; Okhobotov D A; Akopyan E P; Shakhpazyan N K; Shaparov B M; Nesterova O Y; Martirosyan L K; Ekhoyan M M; Osmanov O A
Urologiia; 2023 Dec; (6):95-101. PubMed ID: 38156690
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of human papillomavirus infections in prostatic disease: a cross-sectional study in Iran.
Ghasemian E; Monavari SH; Irajian GR; Jalali Nodoshan MR; Roudsari RV; Yahyapour Y
Asian Pac J Cancer Prev; 2013; 14(5):3305-8. PubMed ID: 23803120
[TBL] [Abstract][Full Text] [Related]
7. Development of an ELISA for sPSP94 and utility of the sPSP94/sPSA ratio as a diagnostic indicator to differentiate between benign prostatic hyperplasia and prostate cancer.
Mhatre DR; Mahale SD; Khatkhatay MI; Desai SS; Jagtap DD; Dhabalia JV; Tongaonkar HB; Desai MP; Dandekar SP; Varadkar AM
Clin Chim Acta; 2014 Sep; 436():256-62. PubMed ID: 24952364
[TBL] [Abstract][Full Text] [Related]
8. The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation.
De Nunzio C; Kramer G; Marberger M; Montironi R; Nelson W; Schröder F; Sciarra A; Tubaro A
Eur Urol; 2011 Jul; 60(1):106-17. PubMed ID: 21497433
[TBL] [Abstract][Full Text] [Related]
9. Oxidised low-density lipoprotein, a possible distinguishing lipid profile biomolecule between prostate cancer and benign prostatic hyperplasia.
Asare GA; Owusu-Boateng E; Asiedu B; Amoah BY; Essendoh E; Otoo RY
Andrologia; 2019 Sep; 51(8):e13321. PubMed ID: 31145504
[TBL] [Abstract][Full Text] [Related]
10. Detection of telomerase activity in prostate massage samples improves differentiating prostate cancer from benign prostatic hyperplasia.
Vicentini C; Gravina GL; Angelucci A; Pascale E; D'Ambrosio E; Muzi P; Di Leonardo G; Fileni A; Tubaro A; Festuccia C; Bologna M
J Cancer Res Clin Oncol; 2004 Apr; 130(4):217-21. PubMed ID: 14749923
[TBL] [Abstract][Full Text] [Related]
11. IGF-II serum levels increase discrimination between benign prostatic hyperplasia and prostate cancer and improve the predictive value of PSA in clinical staging.
Trojan L; Bode C; Weiss C; Mayer D; Grobholz R; Alken P; Michel MS
Eur Urol; 2006 Feb; 49(2):286-92; discussion 292. PubMed ID: 16386354
[TBL] [Abstract][Full Text] [Related]
12. Increased risk of prostate cancer and benign prostatic hyperplasia associated with transforming growth factor-beta 1 gene polymorphism at codon10.
Li Z; Habuchi T; Tsuchiya N; Mitsumori K; Wang L; Ohyama C; Sato K; Kamoto T; Ogawa O; Kato T
Carcinogenesis; 2004 Feb; 25(2):237-40. PubMed ID: 14604900
[TBL] [Abstract][Full Text] [Related]
13. CCR2 and CCR5 genes polymorphisms in benign prostatic hyperplasia and prostate cancer.
Zambra FM; Biolchi V; Brum IS; Chies JA
Hum Immunol; 2013 Aug; 74(8):1003-8. PubMed ID: 23632061
[TBL] [Abstract][Full Text] [Related]
14. [Correlation of high-risk HPV 16/18 infections with prostate cancer].
Huang L; Wu MG; He J; Wei ZS; Lü WX; Song XJ; Zhang Y; Wu SX; Yin YL; Fan YY
Zhonghua Nan Ke Xue; 2016 Jun; 22(6):501-505. PubMed ID: 28963837
[TBL] [Abstract][Full Text] [Related]
15. Differentiation of prostate cancer and benign prostatic hyperplasia: comparisons of the histogram analysis of intravoxel incoherent motion and monoexponential model with in-bore MR-guided biopsy as pathological reference.
Cui Y; Li C; Liu Y; Jiang Y; Yu L; Liu M; Zhang W; Shi K; Zhang C; Zhang J; Chen M
Abdom Radiol (NY); 2020 Oct; 45(10):3265-3277. PubMed ID: 31549212
[TBL] [Abstract][Full Text] [Related]
16. Oxidative stress parameters in patients with prostate cancer, benign prostatic hyperplasia and asymptomatic inflammatory prostatitis: A prospective controlled study.
Kaya E; Ozgok Y; Zor M; Eken A; Bedir S; Erdem O; Ebiloglu T; Ergin G
Adv Clin Exp Med; 2017 Oct; 26(7):1095-1099. PubMed ID: 29211357
[TBL] [Abstract][Full Text] [Related]
17. Occupational risk factors for prostate cancer and benign prostatic hyperplasia: a case-control study in Western Australia.
Fritschi L; Glass DC; Tabrizi JS; Leavy JE; Ambrosini GL
Occup Environ Med; 2007 Jan; 64(1):60-5. PubMed ID: 17018583
[TBL] [Abstract][Full Text] [Related]
18. Using Genetic and Epigenetic Markers to Improve Differential Diagnosis of Prostate Cancer and Benign Prostatic Hyperplasia by Noninvasive Methods in Mexican Patients.
Sánchez BE; Aguayo A; Martínez B; Rodríguez F; Marmolejo M; Svyryd Y; Luna L; Muñoz LA; Jiménez MA; Sotomayor M; Vargas V F; Mutchinick OM
Clin Genitourin Cancer; 2018 Aug; 16(4):e867-e877. PubMed ID: 29571584
[TBL] [Abstract][Full Text] [Related]
19. The role of human papillomavirus infection in prostate carcinoma.
Aghakhani A; Hamkar R; Parvin M; Ghavami N; Nadri M; Pakfetrat A; Banifazl M; Eslamifar A; Izadi N; Jam S; Ramezani A
Scand J Infect Dis; 2011 Jan; 43(1):64-9. PubMed ID: 20662618
[TBL] [Abstract][Full Text] [Related]
20. Temporal Trend in Incidental Prostate Cancer Detection at Surgery for Benign Prostatic Hyperplasia.
Capogrosso P; Capitanio U; Vertosick EA; Ventimiglia E; Chierigo F; Oreggia D; Moretti D; Briganti A; Vickers AJ; Montorsi F; Salonia A
Urology; 2018 Dec; 122():152-157. PubMed ID: 30138683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
